Document is current
Any future updates will be listed below
-
Authors
Hancock, Laura A.
Hennessy, Corinne E.
Solomon, George M.
Dobrinskikh, Evgenia
Estrella, Alani
Hara, Naoko
Hill, David B. https://orcid.org/0000-0002-9270-777X
Kissner, William J.
Markovetz, Matthew R. https://orcid.org/0000-0003-3931-0594
Grove Villalon, Diane E.
Voss, Matthew E.
Tearney, Guillermo J.
Carroll, Kate S.
Shi, Yunlong
Schwarz, Marvin I.
Thelin, William R.
Rowe, Steven M.
Yang, Ivana V.
Evans, Christopher M.
Schwartz, David A. https://orcid.org/0000-0001-6743-8443
- License Information
-
More Information
Article History
Received: 5 March 2018
Accepted: 14 November 2018
First Online: 18 December 2018
Competing interests
: D.A.S. is the founder and chief scientific officer of Eleven P15, a company focused on the early diagnosis and treatment of pulmonary fibrosis. D.A.S. has patents awarded (US Patent no: 8,673,565) and submitted (US Patent application no: 62/250,390, US Patent application no: 62/525,087, and US Patent application no: 62/525,088) for the treatment and diagnosis of fibrotic lung disease. D.E.G.V., M.E.V. and W.R.T. are employees of Parion Sciences. The remaining authors declare no competing interests.
